Literature DB >> 228282

Transformation by Rous sarcoma virus: effects of src gene expression on the synthesis and phosphorylation of cellular polypeptides.

K Radke, G S Martin.   

Abstract

Infection of chicken embryo fibroblasts by Rous sarcoma virus induces a variety of alterations in cellular growth and morphology. We have used two-dimensional polyacrylamide gel electrophoresis to examine the effects of viral transformation on the pattern of synthesis and phosphorylation of cellular polypeptides. Infection by Rous sarcoma virus does not appear to induce the de novo synthesis, or the complete suppression, of any of the [35S]methionine-labeled cellular polypeptides that can be resolved with this technique; however, there are quantitative changes in a minor fraction (approximately 4%) of the [35S]methionine-labeled polypeptides. When cells labeled with [32P]orthophosphate were examined, a phosphorylated polypeptide, Mr 36,000, was detected in transformed cells; this polypeptide appears within 20 min when cells infected by a temperature-sensitive mutant of Rous sarcoma virus are shifted from the nonpermissive to the permissive temperature. Phosphorylation of the 36,000 Mr polypeptide thus represents an early event in the process of transformation, and it is possible that this polypeptide is a target for the kinase activity associated with pp60src.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 228282      PMCID: PMC413110          DOI: 10.1073/pnas.76.10.5212

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Mutants of Rous sarcoma virus with extensive deletions of the viral genome.

Authors:  G S Martin; K Radke; S Hughes; N Quintrell; J M Bishop; H E Varmus
Journal:  Virology       Date:  1979-07-30       Impact factor: 3.616

2.  Phosphorylated and nonphosphorylated forms of avian sarcoma virus polypeptide p19.

Authors:  E Erikson; J S Brugge; R L Erikson
Journal:  Virology       Date:  1977-07-01       Impact factor: 3.616

3.  Identification of a transformation-specific antigen induced by an avian sarcoma virus.

Authors:  J S Brugge; R L Erikson
Journal:  Nature       Date:  1977-09-22       Impact factor: 49.962

4.  Defectiveness of avian myelocytomatosis virus MC29: isolation of long-term nonproducer cultures and analysis of virus-specific polypeptide synthesis.

Authors:  K Bister; M J Hayman; P K Vogt
Journal:  Virology       Date:  1977-10-15       Impact factor: 3.616

5.  Protein kinase activity associated with the avian sarcoma virus src gene product.

Authors:  M S Collett; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

6.  Transformation-defective mutants of Rous sarcoma virus with src gene deletions of varying length.

Authors:  S Kawai; P H Duesberg; H Hanafusa
Journal:  J Virol       Date:  1977-12       Impact factor: 5.103

7.  Transformation parameters in chicken fibroblasts transformed by AEV and MC29 avian leukemia viruses.

Authors:  B Royer-Pokora; H Beug; M Claviez; H J Winkhardt; R R Friis; T Graf
Journal:  Cell       Date:  1978-04       Impact factor: 41.582

8.  Avian myelocytomatosis and erythroblastosis viruses lack the transforming gene src of avian sarcoma viruses.

Authors:  D Stéhelin; T Graf
Journal:  Cell       Date:  1978-04       Impact factor: 41.582

9.  High resolution two-dimensional electrophoresis of basic as well as acidic proteins.

Authors:  P Z O'Farrell; H M Goodman; P H O'Farrell
Journal:  Cell       Date:  1977-12       Impact factor: 41.582

10.  Evidence that the transforming gene of avian sarcoma virus encodes a protein kinase associated with a phosphoprotein.

Authors:  A D Levinson; H Oppermann; L Levintow; H E Varmus; J M Bishop
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

View more
  102 in total

1.  The position of the microtubule-organizing center in directionally migrating fibroblasts depends on the nature of the substratum.

Authors:  K Schütze; A Maniotis; M Schliwa
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

2.  The product of the protooncogene c-src is modified during the cellular response to platelet-derived growth factor.

Authors:  R Ralston; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

3.  Phosphotyrosine - a new protein modification.

Authors:  Tony Hunter
Journal:  Trends Biochem Sci       Date:  1982-07       Impact factor: 13.807

4.  Phosphorylation of talin at tyrosine in Rous sarcoma virus-transformed cells.

Authors:  J E DeClue; G S Martin
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

5.  Purification of the Rous sarcoma virus src kinase by casein-agarose and tyrosine-agarose affinity chromatography.

Authors:  Y Fukami; F Lipmann
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

6.  EPAC1 regulates endothelial annexin A2 cell surface translocation and plasminogen activation.

Authors:  Wenli Yang; Fang C Mei; Xiaodong Cheng
Journal:  FASEB J       Date:  2018-01-05       Impact factor: 5.191

7.  Isolation of a cDNA clone complementary to sequences for a 34-kilodalton protein which is a pp60v-src substrate.

Authors:  H G Tomasiewicz; R Cook-Deegan; D M Chikaraishi
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

8.  Evidence that the Rous sarcoma virus transforming gene product phosphorylates phosphatidylinositol and diacylglycerol.

Authors:  Y Sugimoto; M Whitman; L C Cantley; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

9.  Aspects of the metabolism of the epidermal growth factor receptor in A431 human epidermoid carcinoma cells.

Authors:  S J Decker
Journal:  Mol Cell Biol       Date:  1984-04       Impact factor: 4.272

10.  Four different classes of retroviruses induce phosphorylation of tyrosines present in similar cellular proteins.

Authors:  J A Cooper; T Hunter
Journal:  Mol Cell Biol       Date:  1981-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.